Kalecinski Julie, Régnier-Denois Véronique, Ouédraogo Samiratou, Dabakuyo-Yonli Tienhan Sandrine, Dumas Agnès, Arveux Patrick, Chauvin Franck
Sante Publique. 2015 Mar-Apr;27(2):213-20.
The breast cancer screening programme, proposed to all women between 50 and 69 years, consisting of two-view mammography screening every two years, has been generalized in France since 2004. The programme coexists with opportunistic mammography screening, provided outside official frameworks. This qualitative study was designed to identify the pros and cons of these two screening modes.
Three hundred and forty-five women were randomly selected from women who had participated in a previous quantitative study and who were invited to attend for breast cancer screening in 13 French departments between 2010 and 2011. These women were asked to participate in a face-to-face semistructured interview conducted by a sociologist.
48 women (17 from deprived areas) were interviewed. All chose to be screened for breast cancer either because they feared cancer, or because they wanted to control their own health. Twenty-seven women chose the organized screening programme, which they considered to be trustworthy, as negative mammograms are double checked by a second radiologist. Twenty-one women preferred individual screening, which they considered to be more reliable, less anonymous and providing them with more liberty to take control of their own health.
Gynaecologists play an important role in women’s decision to undergo individual breast cancer screening. They also have an important role to play in the promotion of organized breast cancer screening programme with this public.
面向所有50至69岁女性的乳腺癌筛查项目，包括每两年进行一次双视角乳腺钼靶筛查，自2004年起在法国全面推行。该项目与在官方框架之外提供的机会性乳腺钼靶筛查并存。这项定性研究旨在确定这两种筛查模式的优缺点。
从参与过之前定量研究且在2010年至2011年期间被邀请到法国13个部门进行乳腺癌筛查的女性中随机选取345名女性。这些女性被要求参加由一名社会学家进行的面对面半结构化访谈。
48名女性（17名来自贫困地区）接受了访谈。她们都选择进行乳腺癌筛查，要么是因为害怕患癌，要么是因为想掌控自己的健康状况。27名女性选择了有组织的筛查项目，她们认为该项目值得信赖，因为阴性的乳腺钼靶检查结果会由另一位放射科医生进行二次检查。21名女性更喜欢个体化筛查，她们认为这种筛查更可靠、更少匿名性，并且能让她们有更多自由来掌控自己的健康。
妇科医生在女性决定接受个体化乳腺癌筛查方面发挥着重要作用。他们在向公众推广有组织的乳腺癌筛查项目方面也起着重要作用。
